Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
Location status: Recruiting
Location contact
Eliza Beal, MD
SUB_INVESTIGATOR
Lauren M Hamel, PhD
CONTACT
Lauren M Hamel, PhD
PRINCIPAL_INVESTIGATOR
Susan Eggly, PhD
SUB_INVESTIGATOR
NCT Number: NCT07042191
The overall goal of this research program is to address financial toxicity through the development, testing, and implementation of a multi-level communication intervention. If successful, this intervention could be a companion intervention for Cancer providers in combination with the already in testing DISCO app (Discussions of Cost App) for patients. Participants will:
* complete a baseline survey * attend two one on one meetings, one as part of the development and the second as part of the pilot testing of the intervention.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
Detroit, Michigan, 48201, United States
Location status: Recruiting
Eliza Beal, MD
SUB_INVESTIGATOR
Lauren M Hamel, PhD
CONTACT
Lauren M Hamel, PhD
PRINCIPAL_INVESTIGATOR
Susan Eggly, PhD
SUB_INVESTIGATOR
20 Wayne State University (WSU)/Karmanos Cancer Institute (KCI) oncology care providers (e.g., medical oncologists, nurses, social workers, APP) who treat patients at the KCI Detroit and Farmington Hills clinics where patients are treated for cancer will be recruited. At least two providers from each discipline who treat various cancer types will be included. The study will be discussed at clinic program meetings and then interested providers will be consented. Providers who consent will agree to 1) complete a baseline survey, and 2) attend two one-on-one meetings, one as a part of the DISCO (Discussion of Cost) Provider development (Aim 1) and the second as a part of the DISCO Provider pilot-testing (Aim 2).
To achieve Aim 1, participants will be asked to complete a survey eliciting their demographic and professional characteristics prior to interviews. Then, during one-on-one interviews, which will be audio recorded and subsequently transcribed, the investigators will present the DISCO Provider wireframes and ask participants to provide feedback on the planned content, organization, and implementation. The Investigators will also present participants with strategies identified from research on how to initiate, respond to, and effectively discuss cost concerns. Investigators will ask participants about ideas for website design and training intervention implementation. Participants will be asked to complete a needs assessment interview about their use of digital support tools.
To achieve Aim 2 and pilot test DISCO Provider, participants will again meet one-on-one with the Investigators. Investigators will ask participants to provide feedback on the acceptability and usability of the working version of DISCO Provider, whether participants think it is useful for training providers to discuss cost, if the strategies suggested will likely be effective, and suggestions for improvement. Meetings will be audio recorded, transcribed, and analyzed using similar methods as those in Aim 1
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
A communication intervention for providers to assess financial toxicity in Cancer patients
Time frame: Immediately Post Pilot Test
Success of intervention measured by semi-structured qualitative interview method which addresses acceptability
Time frame: Immediately post pilot test
Success of intervention measured by semi-structured qualitative interview method which addresses usability
Time frame: Immediately Post Pilot Test
Success of intervention measured by semi-structured qualitative interview method which addresses usefulness
Contact information is provided by the study sponsor or research team.
Barbara Ann Karmanos Cancer Institute
Other
DISCO Provider: A Multi-level Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
Acronym: DISCO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07686393
Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT07407348
Body Weight, Healthy
Nottingham, United Kingdom
View Trial DetailsNCT07169630
Alzheimer s Disease, Cognition Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT01399385
Arterial Occlusive Diseases, Arteriosclerosis
Bethesda, Maryland, United States
View Trial Details